Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease. Circulation. 2015;131:495–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization. JACC Cardiovasc Interv. 2014;7:10–9.

Article  PubMed  Google Scholar 

Horie K, Tanaka A, Taguri M, Inoue N. Impact of baseline and postprocedural intravascular ultrasound findings on 1- year primary patency after drug-coated balloon treatment of femoropopliteal lesions. J Endovasc Ther. 2022;29:66–75.

Article  PubMed  Google Scholar 

Horie K, Takahara M, Nakama T, Tanaka A, Tobita K, Hayakawa N, et al. Impact of postoperative lumen gain on the reduction of restenosis risk after endovascular treatment using drug-coated balloon for femoropopliteal lesions assessed by intravascular ultrasound. J Atheroscler Thromb. 2023;30:1142–51.

Article  PubMed  Google Scholar 

Kurata N, Iida O, Takahara M, Asai M, Masuda M, Okamoto S, et al. Clinical impact of the size of drug-coated balloon therapy on restenosis rate in femoropopliteal lesions. J Endovasc Ther. 2023;30:269–80.

Article  PubMed  Google Scholar 

Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, et al. Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. J Endovasc Ther. 2017;24:367–75.

Article  PubMed  Google Scholar 

Tan M, Urasawa K, Koshida R, Haraguchi T, Kitani S, Igarashi M, et al. Comparison of angiographic dissection patterns caused by long or short balloons during balloon angioplasty for chronic femoropoliteal occlusions. J Endovasc Ther. 2018;25:192–200.

Article  PubMed  Google Scholar 

Karashima E, Yoda S, Yasuda S, Kajiyama S, Ito H, Kaneko T. Usefulness of the “non-slip element” percutaneous transluminal angioplasty balloon in the treatment of femoropopliteal arterial lesions. J Endovasc Ther. 2020;27:102–8.

Article  PubMed  Google Scholar 

Horie K, Tanaka A, Taguri M, Kato S, Inoue N. Impact of prolonged inflation times during plain old balloon angioplasty on angiographic dissection in femoropopliteal lesions. J Endovasc Ther. 2018;25:683–91.

Article  PubMed  Google Scholar 

Sugihara M, Mine K, Futami M, Kato Y, Arimura T, Yano M, et al. Efficacy of super slow inflation as lesion preparation for drug-coated balloons in femoropopliteal lesions. Circ Rep. 2020;2:682–90.

Article  PubMed  PubMed Central  Google Scholar 

Fujihara M, Kurata N, Yazu Y, Mori S, Tomoi Y, Horie K, et al. Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther. 2022;37:597–612.

Article  PubMed  Google Scholar 

Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, et al. Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc. 2023;12: e025677.

Article  PubMed  Google Scholar 

Nakama T, Takahara M, Iwata Y, Suzuki K, Tobita K, Hayakawa N et al. Low-dose vs high-dose drug-coated balloon for symptomatic femoropopliteal artery disease. JACC Cardiovasc Interv 2023: 11: S1936–8798(23)01205–0.